Refractory follicular Non-Hodgkin's lymphoma

Also known as: Follicular Non-Hodgkin's Lymphoma Refractory / Refractory follicular non-hodgkin lymphoma

DrugDrug NameDrug Description
DB06769BendamustineAn antineoplastic agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy.
DB00078Ibritumomab tiuxetanA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
DrugDrug NamePhaseStatusCount
DB09054IdelalisibNot AvailableCompleted1